PL3142641T3 - Preparaty do leczenia nadczynności tarczycy - Google Patents
Preparaty do leczenia nadczynności tarczycyInfo
- Publication number
- PL3142641T3 PL3142641T3 PL15734557T PL15734557T PL3142641T3 PL 3142641 T3 PL3142641 T3 PL 3142641T3 PL 15734557 T PL15734557 T PL 15734557T PL 15734557 T PL15734557 T PL 15734557T PL 3142641 T3 PL3142641 T3 PL 3142641T3
- Authority
- PL
- Poland
- Prior art keywords
- hyperthyroidism
- formulations
- treatment
- Prior art date
Links
- 206010020850 Hyperthyroidism Diseases 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102014106749 | 2014-05-13 | ||
| PCT/DE2015/100192 WO2015172769A2 (de) | 2014-05-13 | 2015-05-12 | Formulierungen zur behandlung von hyperthyreose |
| EP15734557.0A EP3142641B1 (de) | 2014-05-13 | 2015-05-12 | Formulierungen zur behandlung von hyperthyreose |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3142641T3 true PL3142641T3 (pl) | 2021-08-23 |
Family
ID=53524526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15734557T PL3142641T3 (pl) | 2014-05-13 | 2015-05-12 | Preparaty do leczenia nadczynności tarczycy |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10369135B2 (pl) |
| EP (1) | EP3142641B1 (pl) |
| CN (1) | CN106714794B (pl) |
| CA (1) | CA2975163C (pl) |
| DE (1) | DE112015002229A5 (pl) |
| ES (1) | ES2856324T3 (pl) |
| PL (1) | PL3142641T3 (pl) |
| PT (1) | PT3142641T (pl) |
| WO (1) | WO2015172769A2 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102016102198A1 (de) | 2016-02-09 | 2017-08-24 | Dendropharm Gmbh | Multidosierapplikator für halbfeste galenische Zubereitungen |
| CN114246081A (zh) | 2020-03-10 | 2022-03-29 | 华中农业大学 | 一种单倍体诱导剂及其使用方法 |
| TWI723802B (zh) * | 2020-03-12 | 2021-04-01 | 矽品精密工業股份有限公司 | 電子封裝件及其製法 |
| EP4134073A1 (en) | 2021-08-11 | 2023-02-15 | HM HerbaMedica GmbH | Pharmaceutical compositions comprising dendritic nanocarriers and cannabis active agents |
| EP4417198A1 (en) | 2023-02-14 | 2024-08-21 | MYOB GmbH in Gründung | Pharmaceutical compositions comprising a psychedelic drug and a dendritic nanocarrier |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1046089C (zh) * | 1993-07-24 | 1999-11-03 | 陈凌 | 外敷用抗甲状腺乳膏 |
| US6365616B1 (en) * | 1998-08-31 | 2002-04-02 | Sentron Medical, Inc. | Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune diseases |
| DE10143962A1 (de) * | 2001-09-07 | 2003-03-27 | Basf Ag | Kosmetische und dermatologische Zubereitungen in Form von O/W-Emulsionen, enthaltend ein aminosubstituiertes Hydroxybenzophenon |
| DE102004039875A1 (de) | 2004-08-17 | 2006-03-09 | Universität Dortmund | Nanotransportsystem mit dendritischer Architektur |
| CN100406063C (zh) * | 2005-05-18 | 2008-07-30 | 陈凌 | 外敷用抗甲状腺软膏及其制备方法 |
| US8124128B2 (en) * | 2005-11-08 | 2012-02-28 | Industrial Technology Research Institute | Amphiphilic block copolymers and nano particles comprising the same |
| DE102006034026A1 (de) | 2006-07-17 | 2008-01-24 | Beiersdorf Ag | Kosmetischer Stift |
| NZ552816A (en) | 2007-01-24 | 2009-05-31 | Bomac Research Ltd | Formulation for transdermal administration of antihyperthyroid drug comprising a penetration enhancer selected from oleic acid, d-limonene, pyrrolidones, a C2-C8 alcohol, glycol ethers, triacetin and combinations thereof |
| WO2011095311A1 (en) | 2010-02-03 | 2011-08-11 | Mivenion Gmbh | Polyanionic multivalent macromolecules for intracellular targeting of proliferation and protein synthesis |
| CN103347498B (zh) * | 2010-10-13 | 2016-04-13 | 沙普药品公司 | 组蛋白脱乙酰酶抑制剂药物配方 |
| CN102631312A (zh) * | 2011-02-09 | 2012-08-15 | 张蔚 | 外敷用复方抗甲状腺凝胶剂及其制备方法 |
| EP2923695A1 (en) | 2014-03-25 | 2015-09-30 | DendroPharm GmbH | Hyperbranched polyglycerol sulfates with hydrophobic cores |
-
2015
- 2015-05-12 WO PCT/DE2015/100192 patent/WO2015172769A2/de not_active Ceased
- 2015-05-12 PL PL15734557T patent/PL3142641T3/pl unknown
- 2015-05-12 CN CN201580038243.7A patent/CN106714794B/zh active Active
- 2015-05-12 ES ES15734557T patent/ES2856324T3/es active Active
- 2015-05-12 DE DE112015002229.5T patent/DE112015002229A5/de not_active Withdrawn
- 2015-05-12 EP EP15734557.0A patent/EP3142641B1/de active Active
- 2015-05-12 US US15/311,030 patent/US10369135B2/en active Active
- 2015-05-12 PT PT157345570T patent/PT3142641T/pt unknown
- 2015-05-12 CA CA2975163A patent/CA2975163C/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015172769A2 (de) | 2015-11-19 |
| US20170143675A1 (en) | 2017-05-25 |
| WO2015172769A3 (de) | 2016-01-14 |
| EP3142641B1 (de) | 2020-11-25 |
| DE112015002229A5 (de) | 2017-06-29 |
| US10369135B2 (en) | 2019-08-06 |
| CA2975163C (en) | 2023-09-19 |
| CN106714794B (zh) | 2021-05-11 |
| CA2975163A1 (en) | 2015-11-19 |
| ES2856324T3 (es) | 2021-09-27 |
| PT3142641T (pt) | 2021-03-02 |
| CN106714794A (zh) | 2017-05-24 |
| EP3142641A2 (de) | 2017-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL280485A (en) | Sustained-release pridopidine preparations | |
| IL247515A0 (en) | Snekribirock for the treatment of leprosy | |
| SG11201609652RA (en) | Treatment of polybacterials infections | |
| GB201415569D0 (en) | Therapeutic Compounds | |
| IL252062A0 (en) | Transdermal compositions | |
| IL249502B (en) | New therapeutic uses of benzylideneguanidine derivatives for the treatment of diseases caused by structurally abnormal proteins | |
| PT3474822T (pt) | Formulações de brincidofovir | |
| IL285882A (en) | Medicinal uses for l–4–chlorokynurenine | |
| ZA201606075B (en) | Pharmaceutical compositions of sitagliptin | |
| PT3122349T (pt) | Composições para o tratamento da autodigestão | |
| GB201416832D0 (en) | Methods of treatment | |
| PL3142641T3 (pl) | Preparaty do leczenia nadczynności tarczycy | |
| ZA201700518B (en) | Use of active compound compositions | |
| PL3184492T3 (pl) | Preparat antyseptyczny | |
| GB201416273D0 (en) | Therapeutic compounds | |
| IL249130B (en) | Preparation of piperidine-4-carbothioamide | |
| GB201412010D0 (en) | Treatment of hypertransaminasemia | |
| IL253125A0 (en) | Preparations based on tetracaine for use as an anesthetic | |
| PL3164110T3 (pl) | Kompozycje farmaceutyczne do leczenia łuszczycy | |
| HUP1400518A2 (hu) | Eljárás tofacitinib elõállítására | |
| GB201407806D0 (en) | Treatment of fibrosis | |
| GB201418268D0 (en) | Composition & methods of treatment | |
| GB201418272D0 (en) | Composition & methods of treatment | |
| GB201418500D0 (en) | Therapeutic compositions | |
| GB201418299D0 (en) | Therapeutic compositions |